Combined Effect of Homocysteine and Uric Acid to Identify Patients With High Risk for Subclinical Atrial Fibrillation.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of the American Heart Association"
DOI: 10.1161/jaha.121.021997
Abstract: Background Subclinical atrial fibrillation (SCAF) is often asymptomatic nonetheless harmful. In patients with cardiac implantable electronic devices, we evaluated the combined performance of homocysteine and uric acid (UA) biomarkers to discriminate high-risk patients for SCAF.… read more here.
Keywords: homocysteine; risk; atrial fibrillation; cardiology ... See more keywords
Subclinical Atrial Fibrillation and Risk of Stroke: Past, Present and Future
Sign Up to like & getrecommendations! Published in 2019 at "Medicina"
DOI: 10.3390/medicina55100611
Abstract: Subclinical atrial fibrillation (SCAF) describes asymptomatic episodes of atrial fibrillation (AF) that are detected by cardiac implantable electronic devices (CIED). The increased utilization of CIEDs renders our understanding of SCAF important to clinical practice. Furthermore,… read more here.
Keywords: atrial fibrillation; fibrillation; fibrillation risk; scaf ... See more keywords